Publicacions en col·laboració amb investigadors/es de Hospital Universitari de Girona Dr. Josep Trueta (23)

2024

  1. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. First-Pass Effect in M1-Occlusion Stroke Patients Treated with Combined Stent-Retriever/Large-Bore Distal Aspiration Catheter Thrombectomy

    Clinical Neuroradiology, Vol. 33, Núm. 3, pp. 701-708

2022

  1. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

  2. Predictors of Functional Outcome after Thrombectomy in Patients with Prestroke Disability in Clinical Practice

    Stroke, Vol. 29, Núm. 2, pp. 845-854

  3. Workflows and Outcomes in Patients With Suspected Large Vessel Occlusion Stroke Triaged in Urban and Nonurban Areas

    Stroke, Vol. 53, Núm. 12, pp. 3728-3740

2021

  1. Blood biomarker panels for the early prediction of stroke-associated complications

    Journal of the American Heart Association, Vol. 10, Núm. 5, pp. 1-8

  2. D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke

    Stroke, Vol. 52, Núm. 3, pp. 852-858

  3. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 8, pp. 1609-1622

  4. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group

    Neurologia, Vol. 36, Núm. 6, pp. 462-471

  5. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology

    Neurologia, Vol. 36, Núm. 4, pp. 305-323

2020

  1. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

  2. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

    Neurological Research and Practice, Vol. 2, Núm. 1

2017

  1. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study

    Stroke, Vol. 48, Núm. 9, pp. 2419-2425

  2. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial

    The Lancet Neurology, Vol. 16, Núm. 5, pp. 369-376

2016

  1. Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia

    Stroke, Vol. 47, Núm. 5, pp. 1381-1384

2015

  1. Phone and video-based modalities of central blinded adjudication of modified rankin scores in an endovascular stroke trial

    Stroke, Vol. 46, Núm. 12, pp. 3405-3410

2014

  1. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy

    Stroke, Vol. 45, Núm. 4, pp. 1046-1052

  2. Safety and effectiveness of endovascular treatment of stroke with unknown time of onset

    Cerebrovascular Diseases, Vol. 37, Núm. 2, pp. 134-140

2013

  1. Hemorrhagic risk of emergent endovascular treatment plus stenting in patients with acute ischemic stroke

    Journal of Stroke and Cerebrovascular Diseases, Vol. 22, Núm. 8, pp. 1326-1331